Cargando…
Intracellular tracing of amyloid vaccines through direct fluorescent labelling
Alzheimer’s disease is a debilitating neurodegenerative condition that progressively causes synaptic loss and major neuronal damage. Immunotherapy utilising Aβ as an active immunogen or via passive treatment utilising antibodies raised to amyloid have shown therapeutic promise. The migratory propert...
Autores principales: | Mold, Matthew, Kumar, Manpreet, Mirza, Ambreen, Shardlow, Emma, Exley, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799327/ https://www.ncbi.nlm.nih.gov/pubmed/29402930 http://dx.doi.org/10.1038/s41598-018-20845-9 |
Ejemplares similares
-
Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations
por: Mold, Matthew, et al.
Publicado: (2016) -
From Stock Bottle to Vaccine: Elucidating the Particle Size Distributions of Aluminum Adjuvants Using Dynamic Light Scattering
por: Shardlow, Emma, et al.
Publicado: (2017) -
Unequivocal identification of intracellular aluminium adjuvant in a monocytic THP-1 cell line
por: Mold, Matthew, et al.
Publicado: (2014) -
Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action
por: Shardlow, Emma, et al.
Publicado: (2018) -
Intracellular Aluminium in Inflammatory and Glial Cells in Cerebral Amyloid Angiopathy: A Case Report
por: Mold, Matthew, et al.
Publicado: (2019)